Wedbush maintains Crescent Biopharma $27 price target
Wedbush maintained a $27.00-per-share price target for Crescent Biopharma, per Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.